BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3792961)

  • 1. [Pharmacological properties of MO-8282, a novel antidepressant].
    Niho T; Ito C; Shibutani Y; Hashizume H; Yamaguchi K
    Nihon Yakurigaku Zasshi; 1986 Oct; 88(4):309-20. PubMed ID: 3792961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacological studies of MO-8282, a new antidepressant].
    Mizota M; Oikawa Y; Nakayama K; Mizuguchi K; Takarada T; Kojima M; Kanehiro H; Funato H; Kayamoto M; Sato M
    Nihon Yakurigaku Zasshi; 1986 Dec; 88(6):457-66. PubMed ID: 2881854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Behavioral pharmacological properties of the novel antidepressant paroxetine, a selective 5-HT uptake inhibitor].
    Yamamoto T; Shibata S; Shimazoe T; Iwasaki K; Ohno M; Minamoto Y; Furuya Y; Miyamoto K; Watanabe S; Ueki S
    Nihon Yakurigaku Zasshi; 1989 Sep; 94(3):189-206. PubMed ID: 2530142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of viloxazine, an antidepressant agent, on biogenic amine uptake mechanisms and related activities.
    Lippman W; Pugsley TA
    Can J Physiol Pharmacol; 1976 Aug; 54(4):494-509. PubMed ID: 974878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Behavioral pharmacology of mianserin hydrochloride, a new antidepressant (author's transl)].
    Kamioka T; Sakai Y
    Nihon Yakurigaku Zasshi; 1980 Sep; 76(6):533-47. PubMed ID: 7193623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of mianserin, a new antidepressant, on the in vitro and in vivo uptake of monoamines.
    Goodlet I; Mireylees SE; Sugrue MF
    Br J Pharmacol; 1977 Oct; 61(2):307-13. PubMed ID: 922259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Behavioral effects of a new antidepressant, setiptiline].
    Yamada K; Furukawa T
    Nihon Yakurigaku Zasshi; 1991 Jan; 97(1):31-9. PubMed ID: 2045013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological properties of beta-amyrin palmitate, a novel centrally acting compound, isolated from Lobelia inflata leaves.
    Subarnas A; Tadano T; Oshima Y; Kisara K; Ohizumi Y
    J Pharm Pharmacol; 1993 Jun; 45(6):545-50. PubMed ID: 8103103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in rat brain monoamine metabolism following the acute administration of lithium chloride in combination with antidepressant drugs.
    Leonard BE
    Arch Int Pharmacodyn Ther; 1975 Jun; 215(2):202-7. PubMed ID: 1164088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Behavior pharmacology of maprotiline, a new antidepressant].
    Ueki S; Fujiwara M; Inoue K; Kataoka Y; Ibii N
    Nihon Yakurigaku Zasshi; 1975 Nov; 71(8):789-815. PubMed ID: 1240830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biphasic effects of typical antidepressants and mianserin, an atypical antidepressant, on aggressive behavior in socially isolated mice.
    Cai B; Matsumoto K; Ohta H; Watanabe H
    Pharmacol Biochem Behav; 1993 Mar; 44(3):519-25. PubMed ID: 8383851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of mianserin on functions of ascending and descending monoaminergic systems, using experimental models (author's transl)].
    Sakai Y; Deguchi T
    Nihon Yakurigaku Zasshi; 1980 Apr; 76(3):213-25. PubMed ID: 6967847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central nervous actions and screening methods of antidepressants.
    Ogura C; Kimishima K
    Folia Psychiatr Neurol Jpn; 1972; 26(4):291-317. PubMed ID: 4144774
    [No Abstract]   [Full Text] [Related]  

  • 14. Biochemical and pharmacological evaluation of the novel antidepressant and serotonin uptake inhibitor 2-(3,4-Dichlorobenzyl)-2-dimethylamino-1-propanol hydrochloride.
    Gouret CJ; Porsolt R; Wettstein JG; Puech A; Soulard C; Pascaud X; Junien JL
    Arzneimittelforschung; 1990 Jun; 40(6):633-40. PubMed ID: 2168703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological studies on a new thymoleptic antidepressant, 1-[3-(dimethylamino)propyl]-5-methyl-3-phenyl-1H-indazole (FS-32).
    Ikeda Y; Takano N; Matsushita H; Shiraki Y; Koide T; Nagashima R; Fujimura Y; Shindo M; Suzuki S; Iwasaki T
    Arzneimittelforschung; 1979; 29(3):511-20. PubMed ID: 114190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacology of lortalamine, a new potent non-tricyclic antidepressant.
    Depin JC; Betbeder-Matibet A; Bonhomme Y; Muller AJ; Berthelon JJ
    Arzneimittelforschung; 1985; 35(11):1655-62. PubMed ID: 4091869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of RS-2232, a potential antidepressant, on the levels of monoamines, precursor amino acids and their related metabolites in mouse brain.
    Yokoyama T; Kamioka T; Iwata N; Kobayashi T
    Jpn J Pharmacol; 1987 Aug; 44(4):413-20. PubMed ID: 3682406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological and biochemical studies on a new compound, 2-(7-indeyloxymethyl)morpholine hydrochloride (YM-08054-1), and its derivatives with potential antidepressant properties.
    Tachikawa S; Harada M; Maeno H
    Arch Int Pharmacodyn Ther; 1979 Mar; 238(1):81-95. PubMed ID: 485706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the mechanism of antidepressant-like action of berberine chloride.
    Kulkarni SK; Dhir A
    Eur J Pharmacol; 2008 Jul; 589(1-3):163-72. PubMed ID: 18585703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of antidepressant activity of 1-(7-methoxy-2-methyl-1,2,3,4-tetrahydro-isoquinolin-4-YL)-cyclohexanol, a β-substituted phenylethylamine in mice.
    Dhir A; Malik S; Kessar SV; Singh KN; Kulkarni SK
    Eur Neuropsychopharmacol; 2011 Sep; 21(9):705-14. PubMed ID: 21277753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.